Purification of an FC-Fusion Protein with [Bathophenathroline:metal] Complexes
Preprint
- 23 December 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
In this study, we aim at assessing an alternative method for purification of Fc-fusion proteins that does not rely on chromatographic media or ligands. Recombinant human acetylcholinesterase, fused to the Fc-domain of human IgG1 (henceforth, AChE-Fc), was purified with precipitated aromatic complexes composed of the bathophenanthroline (henceforth, batho) chelator with either Zn2+ or Cu2+ ions (i.e., [(batho)3:Zn2+] or [(batho)3:Cu2+]) in the presence of polyethylene glycol 6000 (PEG-6000). In a three-step purification process conducted at pH 7, AChE-Fc was captured by the aromatic complexes (Step 1); unbound or weakly bound protein impurities were removed with 20 mM NaCl (Step 2); and AChE-Fc was then extracted at pH 7 (Step 3) using 100 mM Na citrate buffer in 250 mM NaCl. Purified AChE-Fc was monomeric (as determined by dynamic light scattering (DLS) and Native-PAGE); and it's secondary structure was maintained (by far UV circular dichroism (CD) spectroscopy). However, full enzymatic activity was only preserved with the [(batho)3:Zn2+] complex. Interaction between AChE-Fc and [(batho)3:Zn2+] led to ~83-88% overall protein yield. Process upscaling by 30-fold required only proportional increase in the amounts of [(batho)3:Zn2+] and PEG-6000. Efficient (95-97%) chelator recycling was achieved by recrystallization. Chelator leaching into purified AchE-Fc was estimated to be ~0.3% relative to the total amount used. Taken together, this novel procedure has the potential to provide an economical and practical avenue for industrial purification of Fc-fusion proteins.Keywords
All Related Versions
- Version 1, 2024-12-23, Preprints
- Published version: Antibodies, 14 (1), 11.
This publication has 62 references indexed in Scilit:
- Therapeutic Fc‐fusion proteins: Current analytical strategiesJournal of Separation Science, 2020
- The role of more than 40 years of improvement in protein A chromatography in the growth of the therapeutic antibody industryBiotechnology Progress, 2016
- A comparison of Protein A chromatographic stationary phases: Performance characteristics for monoclonal antibody purificationBiotechnology and Applied Biochemistry, 2014
- Fast and scalable purification of a therapeutic full‐length antibody based on process crystallizationBiotechnology and Bioengineering, 2013
- Fc‐fusion proteins: new developments and future perspectivesEMBO Molecular Medicine, 2012
- Downstream antibody purification using aqueous two‐phase extractionBiotechnology Progress, 2010
- PEGylation of therapeutic proteinsBiotechnology Journal, 2010
- Host cell protein clearance during protein a chromatography: Development of an improved column wash stepBiotechnology Progress, 2008
- High-resolution solution NMR structure of the Z domain of staphylococcal protein AJournal of Molecular Biology, 1997
- Protein Purification for Microsequencing by Sequential Native and Denaturing Polyacrylamide Gel Electrophoresis: Application to One ChitinaseAnalytical Biochemistry, 1994